Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.

Abbott India Limited Registered Office: Tel: (91-22) 5046 1000/2000 Godrej BKC, Plot C-68,”G”Block, 3, Corporate Park, Fax : (91-22) 5016 9400 15-16th Floor, Bandra-Kurla Complex, Sion Trombay Road, E-mail : webmasterindia@abbott.com Near MCA Club, Bandra (E), Mumbai - 400 071.India Website : www.abbott.co.in Mumbai - 400 051. India CIN: L24239MH1944PLC007330 November 5, 2026 BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001 Scrip Code: 500488 Dear Sirs, Sub: Outcome of Board Meeting Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Below is the outcome of the Board Meeting held today, i.e., November 5, 2026: Financial Results Pursuant to Regulation 33 of the SEBI Listing Regulations, the Board of Directors approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026, along with the Limited Review Report issued by Walker Chandiok & Co. LLP, Statutory Auditors of the Company. Copy of the same is enclosed herewith. The Meeting of the Board of Directors of the Company commenced at 4.00 pm and concluded at 6.30 pm. This is for your information and record. For Abbott India Limited Kartik Rajendran Managing Director DIN: 09527717